Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer
Clinical trial NCT06081686 · UNKNOWN
Trial details
- NCT number
- NCT06081686
- Sponsor
- Sinotau Pharmaceutical Group
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-13
- Primary completion
- 2025-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.